Thubeena Manickavasagar

Floor 5, 1 Lambeth Palace Rd, London SE1 7EU
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung Cancer.

Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung Cancer.

Journal: Radiology

Published: March 31, 2026

Unilateral Scleral Icterus as a Rare Presentation of Choroidal Metastasis in Transdifferentiated EGFR-Mutant Lung Cancer: A Case Report and Review of the Literature.

Unilateral Scleral Icterus as a Rare Presentation of Choroidal Metastasis in Transdifferentiated EGFR-Mutant Lung Cancer: A Case Report and Review of the Literature.

Journal: Lung Cancer (Auckland, N.Z.)

Published: February 24, 2026

Impact of concurrent colonic CMV infection on clinical outcomes in immune checkpoint inhibitor-induced colitis.

Impact of concurrent colonic CMV infection on clinical outcomes in immune checkpoint inhibitor-induced colitis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 11, 2026

"Hiding in Plain Sight: The Neuro-Protective Benefit of Tropomyosin Receptor Kinase Inhibition in Non-Neurotrophic Receptor Tyrosine Kinase-Driven Lung Cancers": Supporting a Neuroprotective Effect of Lorlatinib Across ALK and ROS1 Targets.

"Hiding in Plain Sight: The Neuro-Protective Benefit of Tropomyosin Receptor Kinase Inhibition in Non-Neurotrophic Receptor Tyrosine Kinase-Driven Lung Cancers": Supporting a Neuroprotective Effect of Lorlatinib Across ALK and ROS1 Targets.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 11, 2026

Renal medullary carcinoma: a systematic review of clinical and radiological findings.

Renal medullary carcinoma: a systematic review of clinical and radiological findings.

Journal: International urology and nephrology

Published: August 20, 2025

PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer.

PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer.

Journal: British journal of cancer

Published: August 08, 2024

Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report.

Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report.

Journal: JTO clinical and research reports

Published: August 02, 2024

Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.

Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.

Journal: European radiology

Published: October 19, 2023

Weakly supervised segmentation models as explainable radiological classifiers for lung tumour detection on CT images.

Weakly supervised segmentation models as explainable radiological classifiers for lung tumour detection on CT images.

Journal: Insights into imaging

Published: May 23, 2023

HER3 expression and MEK activation in non-small-cell lung carcinoma.

HER3 expression and MEK activation in non-small-cell lung carcinoma.

Journal: Lung cancer management

Published: June 04, 2021

Outcomes of systemic therapy for advanced triple-negative breast cancer: A single centre experience.

Outcomes of systemic therapy for advanced triple-negative breast cancer: A single centre experience.

Journal: Breast (Edinburgh, Scotland)

Published: January 08, 2018

Reduced Rates of Severe Complications Following a Change in Anthracycline-Taxane Regimen for Early Breast Cancer: a Single Centre Experience.

Reduced Rates of Severe Complications Following a Change in Anthracycline-Taxane Regimen for Early Breast Cancer: a Single Centre Experience.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: November 30, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026